Lumos Pharma, INC Form 4 insider transactions
Insider transactions: buys and sells by directors, officers and ten percent owners, filed within two business days of the trade.
Lumos Pharma's CEO, Richard J. Hawkins, disposed of shares and stock options as part of a merger agreement with Double Point Ventures LLC.
A Lumos Pharma executive, Zoth Lota S., exercised and disposed of various stock options following the company's merger with DPV Parent, Inc.
Lumos Pharma's Chief Scientific Officer, John C. McKew, exercised and disposed of various stock options and common stock holdings as part of a merger agreement with DPV Parent, Inc.
A Lumos Pharma executive, Chad Allen Johnson, exercised stock options and disposed of shares as part of a merger agreement with Double Point Ventures LLC.
A Lumos Pharma executive, An van Es-Johansson, has exercised and disposed of stock options as part of a merger agreement with Double Point Ventures LLC.
Lumos Pharma executive Raffin Thomas A. disposed of stock options as part of a merger agreement with Double Point Ventures LLC.
Lumos Pharma's Chief Medical Officer, Pisit Duke Pitukcheewanont, disposed of shares and stock options as part of a merger agreement with Double Point Ventures LLC.
Lumos Pharma's executive, Kevin M. Lalande, reports the disposition of common stock and stock options following the merger agreement with Double Point Ventures LLC.
Lumos Pharma's Chief Business Officer, Aaron Schuchart, exercised and disposed of stock options and common stock as part of a merger agreement with Double Point Ventures LLC.
Lumos Pharma's General Counsel, Bradley J Powers, disposed of shares and options as part of a merger agreement with DPV, receiving cash and contingent value rights.
Lumos Pharma's Chief Financial Officer, Lori D. Lawley, exercised and disposed of various stock options and restricted stock units as part of a merger agreement with DPV Parent, Inc.
Lumos Pharma executive Joseph S. McCracken disposed of shares and stock options as part of the merger agreement with Double Point Ventures, receiving cash and contingent value rights.